Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa

Abstract Background Colon cancer incidence is rising in low‐ and middle‐income countries (LMICs), where resource limitations and cost often dictate treatment decisions. In this study, we evaluate the cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer treatm...

Full description

Bibliographic Details
Main Authors: Sarah Xinhui Tan, Yoanna Pumpalova, Alexandra M. Rogers, Kishan Bhatt, Candice‐lee Herbst, Paul Ruff, Alfred I. Neugut, Chin Hur
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Cancer Medicine
Subjects:
adjuvant chemotherapy
cancer treatment
colon cancer
cost‐effectiveness
South Africa
Online Access:https://doi.org/10.1002/cam4.6199

Internet

https://doi.org/10.1002/cam4.6199

Similar Items